Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 873-884

  Araki, T ^a,b   Tanji, H ^b   Fujihara, K ^b   Kato, H ^b   Imai, Y ^a   Mizugaki, M ^a   Itoyama, Y ^b  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 hydroxydopamine; Cholinergic receptors; Dopamine D 2 receptors; High affinity choline uptake sites; Nigrostriatal pathway; Rat; Receptor autoradiography

Indexed keywords

CHOLINERGIC RECEPTOR; DOPAMINE 2 RECEPTOR; HEMICHOLINIUM 3; MUSCARINIC RECEPTOR; OXIDOPAMINE; QUINUCLIDINYL BENZILATE; RACLOPRIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; FOREBRAIN; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; AUTORADIOGRAPHY; CHOLINE; CHOLINERGIC AGENTS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; HEMICHOLINIUM 3; MALE; MEDIAL FOREBRAIN BUNDLE; MUSCARINIC AGONISTS; NERVE DEGENERATION; OXIDOPAMINE; QUINUCLIDINYL BENZILATE; RACLOPRIDE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TRITIUM;

EID: 0033792694     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070039     Document Type: Article

References (42)

1. 1 and calcium antagonist binding sites in selectively vulnerable areas: An autoradiographic study of gerbil brain
2. Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia
3. 3H]hemicholinium-3 binding in the post-ischaemic gerbil brain
4. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle
5. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injections in rats
6. 3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: Evidence from a receptor autoradiographic study
7. 2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat
8. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability
9. Alzheimer's disease: A disorder of cortical cholinergic innervation
10. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra
11. Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions
12. The current clinical picture of Parkinson's disease
13. Ageing and Parkinson's disease: Substantia nigra regional specificity
14. The effect of Parkinson's disease on the ability to maintain a mental set
15. 3H]hemicholinium binding to high-affinity choline uptake sites in aged rat brain
16. Selective delaye3d response deficits in Parkinson's and Alzheimer's disease
17. 3H]choline high-affinity uptake in rat striatal synaptosomes
18. 3H]hemicholinium-3 as a quantitative marker
19. Lesions in nucleus basalis magnocellularis and medial septal area produce quantitatively similar memory impairments
20. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
21. When did Ray Kennedy's Parkinson's disease begin?
22. Rate of cell death in parkinsonism indicates active neuropathological process
23. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain
24. Unilateral ibotenic acid lesions of the caudate putamen results in D2 receptor alterations on the contralateral side
25. Turning behavior in animals
26. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: Quantitative data from ligand binding, in situ hybridization and iontophoresis
27. Cholinergic markers in degenerative parkinsonism: Autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity
28. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment
29. Muscarinic binding and choline acetyltransferase activity in parkisonian subjects with reference to dementia
30. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: Comparison with levodopa treatment
31. Distractibility in early Parkinson's disease
32. Auditory attension in early Parkinson's disease: An impairment in focused attention
33. Molecular biology of dopamine receptors
34. Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals
35. Animal models of Alzheimer's disease: Experimental cholinergic denervation
36. 2 receptor mRNA in rat brain
37. New insights into dopamine receptors in the central nervous system
38. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat
39. Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system
40. Time course changes in the dopam inergic nigrostriatal system following transection of the medial forebrain bundle: Detection of oxidatively modified proteins in substantia nigra
41. 3H]hemicholinium-3 binding sites in the rat central nervous system: A novel biochemical marker for mapping the distribution of cholinergic nerve terminals